Increased number of proliferating cells in oral epithelium from smokers and ex-smokers.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 9813726)

Published in Oral Oncol on July 01, 1998

Authors

M G van Oijen1, M M Gilsing, G Rijksen, G J Hordijk, P J Slootweg

Author Affiliations

1: Department of Pathology, Jordan Laboratory, University Hospital Utrecht, The Netherlands. M.G.C.T.vanOijen@lab.azu.nl

Articles by these authors

Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol (2000) 3.49

An analysis of the interrelationship of the mixed odontogenic tumors--ameloblastic fibroma, ameloblastic fibro-odontoma, and the odontomas. Oral Surg Oral Med Oral Pathol (1981) 2.64

Malignant ameloblastoma or ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol (1984) 2.51

Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ (1991) 2.48

Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res (1992) 2.00

c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol (1996) 1.75

Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ (1993) 1.65

Identification of connexin43 as a functional target for Wnt signalling. J Cell Sci (1998) 1.64

Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys (2001) 1.63

Gain-of-function mutations in the tumor suppressor gene p53. Clin Cancer Res (2000) 1.50

Myxoma of the jaws. An analysis of 15 cases. J Maxillofac Surg (1986) 1.47

Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol Biomarkers Prev (2000) 1.46

A case of cystic adventitial disease of the popliteal artery demonstrated by magnetic resonance imaging. J Vasc Surg (1993) 1.45

p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem (2000) 1.44

[Tumor growth during the waiting period for radiotherapy in patients with oropharyngeal carcinoma]. Ned Tijdschr Geneeskd (2003) 1.42

[Arguments favouring the pharmacotherapy of Bells' palsy]. Ned Tijdschr Geneeskd (2005) 1.40

p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene (1998) 1.38

Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett (1998) 1.36

Long-term quality of life of patients with head and neck cancer. Laryngoscope (2000) 1.32

Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer (2001) 1.30

Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest (1994) 1.23

Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol (1998) 1.17

Warthin's tumour and smoking. B-ENT (2005) 1.17

Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol (2006) 1.15

Osteosarcoma of the jaw bones. Analysis of 18 cases. J Maxillofac Surg (1985) 1.15

Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck (2000) 1.13

Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol (2001) 1.13

Extranodal non-Hodgkin's lymphoma of the oral tissues. An analysis of 20 cases. J Maxillofac Surg (1985) 1.13

Psychological factors and patient delay in patients with head and neck cancer. Eur J Cancer (2004) 1.10

Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma. Oral Oncol (2009) 1.10

A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy. Oral Oncol (1999) 1.08

Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens. J Pathol (1997) 1.07

Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. Ann Surg (2000) 1.07

Bio-energetic response of the heart to dopamine following brain death-related reduced myocardial workload: a phosphorus-31 magnetic resonance spectroscopy study in the cat. J Heart Lung Transplant (1999) 1.06

Glycosaminoglycans in myxoma of the jaw: a biochemical study. J Oral Pathol (1985) 1.06

Leiomyosarcomas of the oral cavity. Report of four cases and review of the literature. J Craniomaxillofac Surg (1993) 1.05

The ameloblastoma, the controversial approach to therapy. J Maxillofac Surg (1985) 1.04

Condylar hyperplasia. A clinico-pathological analysis of 22 cases. J Maxillofac Surg (1986) 1.03

Endotoxin-induced inflammation and injury of the guinea pig respiratory airways cause bronchial hyporeactivity. Am Rev Respir Dis (1988) 1.02

Chromosomal instability predicts metastatic disease in patients with insulinomas. Endocr Relat Cancer (2005) 1.02

Differences in coping style and locus of control between older and younger patients with head and neck cancer. Clin Otolaryngol (2005) 1.02

Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Cancer Res (1989) 1.01

Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders. J Oral Pathol Med (1998) 1.01

Histologic changes after vertebroplasty. J Bone Joint Surg Am (2004) 1.01

Pyruvate kinase activity and isozyme composition in normal fibrous tissue and fibroblastic proliferations. Cancer (1991) 1.00

F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer. Head Neck (2001) 1.00

A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck (1999) 1.00

Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates. J Biol Chem (1990) 0.99

Reasons for non-standard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol (2004) 0.99

Purification and some properties of human erythrocyte hexokinase. Biochim Biophys Acta (1976) 0.99

CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes. Eur J Immunol (1999) 0.99

Negative and positive influences of social support on depression in patients with head and neck cancer: a prospective study. Psychooncology (2000) 0.98

The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma. J Craniomaxillofac Surg (1991) 0.98

Landmarks for parotid gland surgery. J Laryngol Otol (2001) 0.98

Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma? Clin Otolaryngol Allied Sci (2000) 0.98

Multinucleate giant cells in sublabial salivary gland tissue in Sjögren's syndrome. A diagnostic pitfall. Virchows Arch A Pathol Anat Histopathol (1984) 0.97

T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results. Clin Otolaryngol Allied Sci (1992) 0.97

Synchronous and metachronous tumours in patients with head and neck cancer. J Laryngol Otol (1983) 0.96

Verrucous hyperplasia or verrucous carcinoma. An analysis of 27 patients. J Maxillofac Surg (1983) 0.96

Glycolytic enzyme activities in breast cancer metastases. Tumour Biol (1988) 0.96

Morphometric study of histological changes in sublabial salivary glands due to aging process. J Clin Pathol (1986) 0.95

Interobserver and intraobserver variability in the histologic assessment of oral lichen planus. J Oral Pathol Med (1999) 0.95

Ghost cell odontogenic carcinoma. Int J Oral Maxillofac Surg (2006) 0.94

Evaluation of the VX2 rabbit auricle carcinoma as a model for head and neck cancer in humans. J Craniomaxillofac Surg (2000) 0.94

Osteochondroma of the mandibular condyle. A case report. Int J Oral Maxillofac Surg (1996) 0.93

Expression of a folate binding protein in L1210 cells grown in low folate medium. Cancer Res (1989) 0.93

Mandibular invasion by oral squamous cell carcinoma. Clinical aspects. J Craniomaxillofac Surg (1990) 0.93

Regulation of human erythrocyte hexokinase. The influence of glycolytic intermediates and inorganic phosphate. Biochim Biophys Acta (1977) 0.92

Orbital exenteration in surgery of malignant neoplasms of the paranasal sinuses. The value of preoperative computed tomography. Arch Otolaryngol Head Neck Surg (1989) 0.92

Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems. Cancer Res (1991) 0.92

Assessment of mandibular invasion of squamous cell carcinoma by various modes of imaging: constructing a diagnostic algorithm. Int J Oral Maxillofac Surg (2008) 0.92

Non-smoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population. Oral Dis (2007) 0.91

Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch-Nyhan syndrome. Hum Genet (1981) 0.91

Prognostic factors for survival in patients with T3 laryngeal carcinoma. Am J Surg (1992) 0.91

Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumour Biol (1987) 0.91

Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas. Cancer Res (1987) 0.91

The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Eur J Cancer B Oral Oncol (1994) 0.90

Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor. J Biol Chem (1995) 0.90

Health risks associated with inhaled nasal toxicants. Crit Rev Toxicol (2001) 0.90

Prediction of depression 6 months to 3 years after treatment of head and neck cancer. Head Neck (2001) 0.89

Primary B-cell malignant lymphoma of the maxilla with a sarcomatous pattern and multilobated nuclei. Cancer (1984) 0.89

Current indications for (adeno)tonsillectomy in children: a survey in The Netherlands. Int J Pediatr Otorhinolaryngol (2003) 0.89

Endomyocardial biopsies after heart transplantation. The presence of immunoglobulin/immune complex deposits. Transplantation (1989) 0.89

Review article. The rat incisor in toxicologic pathology. Toxicol Pathol (1996) 0.89

Acute humoral rejection after heart transplantation. Transplantation (1988) 0.89

The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro. J Immunol (1984) 0.89

Generalized hexokinase deficiency in the blood cells of a patient with nonspherocytic hemolytic anemia. Blood (1983) 0.88

The natural course of an ossifying fibroma. A case report. Int J Oral Maxillofac Surg (1999) 0.88

Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Cancer Res (1989) 0.88

A new and highly sensitive immunohistologic diagnostic criterion for Sjögren's syndrome. Arthritis Rheum (1989) 0.88

Localized infantile myofibromatosis. Report of a case originating in the mandible. J Maxillofac Surg (1984) 0.88

Prediction of depressive symptomatology after treatment of head and neck cancer: the influence of pre-treatment physical and depressive symptoms, coping, and social support. Head Neck (2000) 0.88

Compartmentation of hexokinase in human blood cells. Characterization of soluble and particulate enzymes. Biochim Biophys Acta (1982) 0.87

Sclerosing polycystic adenosis: a case report. B-ENT (2006) 0.87

The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer (2000) 0.87